Building muscle depends on several factors and isn't something that'll happen overnight after just one workout.

Nine predictions for how AI will reshape music licensing, catalog valuation, royalties, and power dynamics across artists, ...

Do not focus only on weight, but waist size matters!’ 'Beer belly' or abdominal obesity has been largely identified as a ...

A biologist explains the surprising evolutionary math behind how the blue whale became the largest animal that has ever lived ...

At a time when modern performance cars chase four-figure horsepower and 16-cylinder engines, Oldsmobile once built a best ...

Drawing often feels flat and uncertain when it is approached as a collection of outlines, but this video explains why ...

The drug candidate aims to reduce fat and is being developed for use alongside existing GLP-1 receptor agonist therapies.

Caliway Biopharmaceuticals (TWSE: 6919) today announced that it has completed the submission of an Investigational New Drug (IND) application to the U.S. FDA for a Phase 2 clinical study of its ...

Caliway Biopharmaceuticals completes submission of IND application to US FDA for phase 2 study of CBL-514 for weight management: New Taipei City Monday, December 29, 2025, 11:00 H ...

While 2025 has been crucial for establishing the clinical credibility of GLP-1 agonists like semaglutide (Wegovy) and tirzepatide (Mounjaro), 2026 will mark the 'patent cliff' that will democratise ...

From a familiar presence in kitchens and gym bags to café menus, chia seeds have been widely promoted as an easy addition to ...

Caliway has completed submission of an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for a Phase 2 clinical study of CBL-514 ...